Biologics

OssDesign's Catalyst nanosynthetic bone graft has been used in 1,000 patients, the medtech company said May 9.

Bioventus' CEO Ken Reali left his post on April 4.

Aurora-based University of Colorado Medicine opened the CU Medicine Regenerative Medicine, Hand and Spine Center in Englewood.

Here are five updates in orthobiologics and regenerative medicine to know from the first quarter of 2023:

The world's first viable bone matrix that provides lineage-committed bone cells, LifeNet Health's ViviGen MIS, is now available for use in trauma procedures. 

Here are five updates in regenerative medicine since the end of December:

Orthobiologics company Royal Biologics has commercially launched a new platelet-rich plasma system, Bioincyte. 

A three-year study of Creative Medical Technology Holdings' StemSpine procedure found it was effective for addressing chronic lower back pain.

Orthobiologics company DiscGenics shared data supporting its IDCT (rebonuputemcel) allogeneic discogenic progenitor cell therapy for lumbar degenerative disc disease.

Apex Biologix has chosen Jim Rogers to be the company's next CEO.